COVID-19 Joint Biomanufacturing Subcommittee

 

COVID-19 Joint Biomanufacturing Subcommittee Meeting: June 23, 2020

Proposal Considered: Fill and Finish and Bill of Materials
Name of Members: Nature of Interest Action Taken
  1. J. Mark Lievonen, C.M.
M. Lievonen was previously employed by Sanofi Pasteur (past president, retired in 2016) and holds modest shares (current value of approximately $500). He is no longer active with the company. As there are not direct, material linkages, it was not considered a conflict and recusal was not deemed necessary.
  1. Joanne Langley, MD
None N/A
  1. Nancy Harrison, MBA
None N/A
  1. Cédric Bisson, MD
None N/A
  1. Robert Brunham, MD
R. Brunham has an application submitted for funding under the COVID-19 Strategic Innovation Fund – this application does not relate to biomanufacturing.  As there are not direct, material linkages, it was not considered a conflict and recusal was not deemed necessary.
  1. Christopher Procyshyn
C. Procyshyn is the co-founder and CEO of Vanrx, a company that produces biomanufacturing machinery Deemed a conflict of interest, C. Procyshyn recused himself from the deliberations and recommendations.
  1. Benjamin Rovinski, PhD
None N/A

COVID-19 Joint Biomanufacturing Subcommittee Meeting: June 25th; July 6, 2020

Proposal Considered: National Research Council – Royalmount (announced  –  August 31)
Name of Members: Nature of Interest Action Taken
  1. J. Mark Lievonen, C.M.
None N/A
  1. Joanne Langley, MD
None N/A
  1. Nancy Harrison, MBA
None N/A
  1. Cédric Bisson, MD
Did not attend the meeting. N/A
  1. Robert Brunham, MD
None N/A
  1. Christopher Procyshyn
C. Procyshyn is the co-founder and CEO of Vanrx, a company that produces biomanufacturing machinery. Prior to the creation of the task force, NRC had purchased a Vanrx machine. The CVTF played no role in the advice on the purchase of the machine. As there are not direct, material linkages, it was not considered a conflict and recusal was not deemed necessary.
  1. Benjamin Rovinski, PhD
None N/A